Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Publications indexed to the term Infusions, Subcutaneous

FacultyTitle
1Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study. (Anderson JT, Bonagura VR, Cowan J, Hsu C, Mustafa SS, Patel NC, Routes JM, Sriaroon P, Vinh DC, Hofmann JH, Praus M, Rojavin MA) J Clin Immunol 2021 Feb;41(2):458-469       4 Citations
1Subcutaneous and Intravenous Treprostinil Pharmacokinetics in Children With Pulmonary Vascular Disease. (Hall K, Ogawa M, Sakarovitch C, Hopper RK, Adamson GT, Hanna B, Ivy DD, Miller-Reed K, Yung D, McCarthy E, Siehr-Handler SL, Feinstein JA) J Cardiovasc Pharmacol 2019 Jun;73(6):383-393       9 Citations
1Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics. (Siehr SL, Ivy DD, Miller-Reed K, Ogawa M, Rosenthal DN, Feinstein JA) J Heart Lung Transplant 2013 May;32(5):546-52       60 Citations
1Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. (Farrokhi F, Klindukhova O, Chandra P, Peng L, Smiley D, Newton C, Pasquel F, Fereira ME, Umpierrez G) J Diabetes Sci Technol 2012 Sep 01;6(5):1022-9       63 Citations
1Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency. (Wasserman RL, Melamed I, Stein MR, Gupta S, Puck J, Engl W, Leibl H, McCoy B, Empson VG, Gelmont D, Schiff RI, IGSC, 10% with rHuPH20 Study Group) J Allergy Clin Immunol 2012 Oct;130(4):951-7.e11       147 Citations
1A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department. (Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT) Ann Emerg Med 2010 Jul;56(1):1-6       68 Citations
1Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. (Khanna D, Clements PJ, Furst DE, Korn JH, Ellman M, Rothfield N, Wigley FM, Moreland LW, Silver R, Kim YH, Steen VD, Firestein GS, Kavanaugh AF, Weisman M, Mayes MD, Collier D, Csuka ME, Simms R, Merkel PA, Medsger TA Jr, Sanders ME, Maranian P, Seibold JR, Relaxin Investigators and the Scleroderma Clinical Trials Consortium) Arthritis Rheum 2009 Apr;60(4):1102-11       123 Citations